Pulse Return On Assets from 2010 to 2025

PLSE Stock  USD 19.63  1.84  10.34%   
Pulse Biosciences' Return On Assets are decreasing over the years with slightly volatile fluctuation. Return On Assets are expected to dwindle to -0.86. Return On Assets is a profitability ratio that indicates the percentage of profit Pulse Biosciences earns in relation to its overall resources. It is calculated by dividing net income by total assets. View All Fundamentals
 
Return On Assets  
First Reported
2010-12-31
Previous Quarter
(0.82)
Current Value
(0.86)
Quarterly Volatility
0.43692034
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pulse Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pulse Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 1.6 M, Selling General Administrative of 14.7 M or Research Development of 18.1 M, as well as many indicators such as Price To Sales Ratio of 234, Dividend Yield of 0.0 or PTB Ratio of 16.01. Pulse financial statements analysis is a perfect complement when working with Pulse Biosciences Valuation or Volatility modules.
  
Check out the analysis of Pulse Biosciences Correlation against competitors.
For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.

Latest Pulse Biosciences' Return On Assets Growth Pattern

Below is the plot of the Return On Assets of Pulse Biosciences over the last few years. It is a profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets. Pulse Biosciences' Return On Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pulse Biosciences' overall financial position and show how it may be relating to other accounts over time.
Return On Assets10 Years Trend
Slightly volatile
   Return On Assets   
       Timeline  

Pulse Return On Assets Regression Statistics

Arithmetic Mean(0.52)
Geometric Mean0.24
Coefficient Of Variation(83.70)
Mean Deviation0.37
Median(0.51)
Standard Deviation0.44
Sample Variance0.19
Range1.178
R-Value(0.84)
Mean Square Error0.06
R-Squared0.70
Significance0.000055
Slope(0.08)
Total Sum of Squares2.86

Pulse Return On Assets History

2025 -0.86
2024 -0.82
2023 -0.71
2022 -0.76
2021 -1.16
2020 -1.2
2019 -1.1

About Pulse Biosciences Financial Statements

Pulse Biosciences stakeholders use historical fundamental indicators, such as Pulse Biosciences' Return On Assets, to determine how well the company is positioned to perform in the future. Although Pulse Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pulse Biosciences' assets and liabilities are reflected in the revenues and expenses on Pulse Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pulse Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Assets(0.82)(0.86)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Pulse Biosciences is a strong investment it is important to analyze Pulse Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulse Biosciences' future performance. For an informed investment choice regarding Pulse Stock, refer to the following important reports:
Check out the analysis of Pulse Biosciences Correlation against competitors.
For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulse Biosciences. If investors know Pulse will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulse Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.82)
Return On Assets
(0.38)
Return On Equity
(0.70)
The market value of Pulse Biosciences is measured differently than its book value, which is the value of Pulse that is recorded on the company's balance sheet. Investors also form their own opinion of Pulse Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pulse Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulse Biosciences' market value can be influenced by many factors that don't directly affect Pulse Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulse Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulse Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulse Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.